RxDoctor Payments Data

Allen Schlein, MD

Orthopaedic Surgery · Bridgeport, CTNPI 1316046428

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.7%), other and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 36.5% of the total. 2025 is the largest year on record at $1,248, 2.1 times the $590 reported in 2019.

$3,800in general payments, 2019–2025

Across 58 payments — averaging $65.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Amgen$1K
  • Gotham Surgical Solutions & Devices, Inc.$483
  • Globus Medical$453
  • Stryker$141
  • Radius Health, Inc.$94
  • plus $90 from 4 others

What the payments were for

  • Food & beverage$2,00253%
  • Education$48313%
  • Other$1,31535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)7$1,387
Amgen29$1,152
Gotham Surgical Solutions & Devices, Inc.1$483
Globus Medical(2 entities)10$453
Stryker1$141
Radius Health, Inc.6$94
Pacira Therapeutics, Inc.1$29
Mindray DS USA, Inc.1$28
Smith+Nephew1$18
Avanos Medical1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,800 in reported general payments places this provider in the 55th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024
$6,157
Medicare patients
21
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Evenity (2 Syringes)Romosozumab-Aqqg12$29,611
Acetaminophen-CodeineAcetaminophen With Codeine11$59
Meloxicam19$29

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEvenity (2 Syringes)$1,152$29,61112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 273 orthopaedic surgery providers in Connecticut.

Other orthopaedic surgery in Bridgeport

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →